LEBUHN ROBERT

CIK 00010079312 companiesEAST RUTHERFORD, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001007931

Recent Transactions

23 trades

Award
ENZON PHARMACEUTICALS, INC.$ENZN
Stock Option (Right to Buy)
2006-01-03+15,000→ 15,000 total
Exercise/Conversion
CAMBREX CORP
Stock Option (Right to Buy)
2005-04-28+2,000→ 19,000 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2005-04-26$11.44/sh+1,500→ 1,796 total
Award
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2004-07-01+1,989→ 15,796 total
Award
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2004-07-01+1,989→ 15,796 total
Award
CAMBREX CORP
Stock Option (Right to Buy)
2004-04-22+2,000→ 18,500 total
Award
CAMBREX CORP
Stock Option (Right to Buy)
2004-04-22+2,000→ 18,500 total
Award
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock (right to buy)
2004-01-02+5,000→ 5,000 total
Award
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock (right to buy)
2004-01-02+5,000→ 5,000 total
Award
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock Right
2003-12-31+335→ 335 total
Award
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock Right
2003-12-31+335→ 335 total
Exercise/Conversion
CAMBREX CORP
Common Stock
2003-10-27$6.63/sh+3,000→ 3,296 total
Exercise/Conversion
CAMBREX CORP
Stock Option (Right to Buy)
2003-10-27−3,000→ 0 total
Award
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock Right
2003-09-30+344→ 344 total
Award
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock Right
2003-09-30+344→ 344 total
Gift
CAMBREX CORP
Common Stock
2003-09-03$21.05/sh−1,000→ 296 total
Gift
CAMBREX CORP
Common Stock
2003-09-03$21.05/sh−1,000→ 296 total
Sale
CAMBREX CORP
Common Stock
2003-08-28$21.05/sh−2,000→ 1,296 total
Sale
CAMBREX CORP
Common Stock
2003-08-28$21.05/sh−2,000→ 1,296 total
Other
CAMBREX CORP
Common Stock
1988-08-08+0→ 3,000 total
Other
CAMBREX CORP
Common Stock
1988-08-08+0→ 3,000 total
Other
CAMBREX CORP
Common Stock
1988-08-08+0→ 1,000 total
Other
CAMBREX CORP
Common Stock
1988-08-08+0→ 1,000 total

Companies

Recent Filings

Address

ONE MEADOWLANDS PLAZA

EAST RUTHERFORD, NJ, 07073

View on SEC.gov